Commonwealth Equity Services LLC Has $833,000 Holdings in Apyx Medical Co. (NASDAQ:APYX)

Commonwealth Equity Services LLC boosted its holdings in shares of Apyx Medical Co. (NASDAQ:APYX) by 3.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 527,061 shares of the company’s stock after purchasing an additional 15,500 shares during the period. Commonwealth Equity Services LLC owned 1.40% of Apyx Medical worth $833,000 as of its most recent SEC filing.

Separately, Raymond James Financial Inc. acquired a new position in Apyx Medical during the 4th quarter worth $134,000. 55.33% of the stock is owned by institutional investors and hedge funds.

Apyx Medical Stock Down 1.6 %

NASDAQ APYX opened at $1.23 on Thursday. The stock has a market capitalization of $46.49 million, a P/E ratio of -1.48 and a beta of 1.18. Apyx Medical Co. has a 52 week low of $0.93 and a 52 week high of $1.99. The company has a debt-to-equity ratio of 3.03, a quick ratio of 4.52 and a current ratio of 5.46. The stock has a fifty day moving average of $1.33 and a 200-day moving average of $1.38.

Apyx Medical (NASDAQ:APYX) last announced its quarterly earnings data on Thursday, March 13th. The company reported ($0.12) EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.01. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. The firm had revenue of $14.22 million during the quarter, compared to analyst estimates of $13.39 million. On average, equities research analysts forecast that Apyx Medical Co. will post -0.68 EPS for the current year.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.